CN Patent

CN117384162A — 选择性her2抑制剂

Assigned to Zhejiang Wenda Pharmaceutical Technology Co ltd · Expires 2024-01-12 · 2y expired

What this patent protects

本发明提供了选择性HER2抑制剂。具体地，本发明提供了一种如式I所示的化合物或其药学上可接受的盐，所述的化合物如式I所示，其中各基团变量如本文中定义。

USPTO Abstract

本发明提供了选择性HER2抑制剂。具体地，本发明提供了一种如式I所示的化合物或其药学上可接受的盐，所述的化合物如式I所示，其中各基团变量如本文中定义。

Drugs covered by this patent

Patent Metadata

Patent number
CN117384162A
Jurisdiction
CN
Classification
—
Expires
2024-01-12
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Wenda Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.